CYTOSORBENTS CORPORATION — Net Income by Fiscal Year
29 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0e3001dc-87e9-4d7d-99a3-82071f138460/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-8.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-073005 |
| FY 2024 | $-20.7M | 2024-01-01 – 2024-12-31 | evidence 0001104659-26-036451 |
| FY 2023 | $-29.2M | 2023-01-01 – 2023-12-31 | evidence 0001410578-25-000591 |
| FY 2022 | $-32.8M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000234 |
| FY 2021 | $-24.6M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000331 |
| FY 2020 | $-7.8M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-033790 |
| FY 2019 | $-19.3M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-029712 |
| FY 2018 | $-17.2M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-012774 |
| FY 2017 | $-8.5M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-013618 |
| FY 2016 | $-11.8M | 2016-01-01 – 2016-12-31 | evidence 0001144204-18-013618 |
| FY 2015 | $-9.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-18-013618 |
| FY 2014 | $-9.3M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-020124 |
| FY 2013 | $-93.5M | 1997-01-22 – 2014-03-31 | evidence 0001144204-14-030424 |
| FY 2012 | $-89.4M | 1997-01-22 – 2013-03-31 | evidence 0001144204-13-029672 |
| FY 2011 | $-85.6M | 1997-01-22 – 2012-03-31 | evidence 0001144204-12-029748 |
| FY 2010 | $-2.9M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018905 |
| FY 2009 | $-2.7M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-018905 |
| FY 2008 | $-3.0M | 2008-01-01 – 2008-12-31 | evidence 0001144204-12-018905 |
| FY 2007 | $-3.4M | 2007-01-01 – 2007-12-31 | evidence 0001144204-12-018905 |
| FY 2006 | $-76.7M | 2006-01-01 – 2006-12-31 | evidence 0001144204-14-019382 |
| FY 2005 | $-3.7M | 2005-01-01 – 2005-12-31 | evidence 0001144204-12-018905 |
| FY 2004 | $-1.1M | 2004-01-01 – 2004-12-31 | evidence 0001144204-12-018905 |
| FY 2003 | $-6.0M | 2003-01-01 – 2003-12-31 | evidence 0001144204-12-018905 |
| FY 2002 | $-11.9M | 2002-01-01 – 2002-12-31 | evidence 0001144204-12-018905 |
| FY 2001 | $-15.4M | 2001-01-01 – 2001-12-31 | evidence 0001144204-12-018905 |
| FY 2000 | $-3.1M | 2000-01-01 – 2000-12-31 | evidence 0001144204-14-019382 |
| FY 1999 | $-10.8M | 1999-01-01 – 1999-12-31 | evidence 0001144204-14-019382 |
| FY 1998 | $-1.9M | 1998-01-01 – 1998-12-31 | evidence 0001144204-12-018905 |
| FY 1997 | $-5.3M | 1997-01-22 – 1997-12-31 | evidence 0001144204-12-018905 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CYTOSORBENTS CORPORATION — all facts · Revenue · Operating Income